Levorphanol tartrate (in methanol aS A

CAS: 125-72-4

Ref. 3D-AAA12572

Produktinformation

• Name: Levorphanol tartrate (in methanol aS A
• Synonyme: 17-Methylmorphinan-3-Ol 2,3-Dihydroxybutanedioate (Salt), 17-Methylmorphinan-3-Ol 2,3-Dihydroxybutanedioate Hydrate (1:1:2), 2H-10,4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, tartrate, <span class="text-smallcaps">D</span>-(-)-Levorphanol tartrate, Lemoran, Levo-Dromoran, Levorphan tartrate, Levorphanol Tartrate, Levorphanol bitartrate, Morphinan-3-ol, 17-methyl-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt), Morphinan-3-ol, 17-methyl-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1) (salt), Morphinan-3-ol, 17-methyl-, tartrate (1:1) (salt), NSC 91012, Nih 4590, Ro 1-5431/7, Tartaric acid, compd. with 1,3,4,9,10,10a-hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol, l-3-Hydroxy-N-methylmorphinan bitartrate, l-3-Hydroxy-N-methylmorphinan tartrate

Beschreibung

Levorphanol tartrate is a potent analgesic that is used for the treatment of severe pain. It works by binding to opioid receptors in the central nervous system, which results in the inhibition of pain signals. Levorphanol tartrate has also been shown to have anticancer properties, as it induces apoptosis in cancer cells and inhibits tumor growth. Additionally, this drug has been found to have an inhibitory effect on chitinase activity, which may be useful in the treatment of inflammatory diseases such as asthma and arthritis. Levorphanol tartrate analogs have also been investigated for their potential as kinase inhibitors, with promising results in preclinical studies. This drug is available as a methanol solution and is excreted primarily in urine after administration.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 407.5 g/mol
• Formel: C₂₁H₂₉NO₇
• Reinheit: Min. 95%